ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
122 hedge funds and large institutions have $586M invested in Array Biopharma Inc in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 38 increasing their positions, 35 reducing their positions, and 9 closing their positions.
Holders
122
Holders Change
+10
Holders Change %
+8.93%
% of All Funds
3.26%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
21
Increased
38
Reduced
35
Closed
9
Calls
$4.84M
Puts
$4.32M
Net Calls
+$517K
Net Calls Change
+$1.24M
Top Buyers
| 1 |
RG
1
Redmile Group
San Francisco,
California
|
$56.1M |
| 2 |
2
First Manhattan
New York
|
$6.15M |
| 3 |
3
State of Wisconsin Investment Board
Madison,
Wisconsin
|
$4.73M |
| 4 |
4
Axa
Paris,
France
|
$4.04M |
| 5 |
O
5
OrbiMed
New York
|
$34.3M |
Top Sellers
| 1 |
BI
1
BVF Inc
San Francisco,
California
|
$55.7M |
| 2 |
QF
2
QVT Financial
New York
|
$1.71M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$22.9M |
| 4 |
KIA
4
Kopp Investment Advisors
Bloomington,
Minnesota
|
$2.84M |
| 5 |
AC
5
Apex Capital
Orinda,
California
|
$9.47M |
